Back to results
US 2014/0235528 A1Published application
Inhibiting gs-fdh to modulate no bioactivity
AssigneeDuke University
InventorsJonathan S. Stamler, Limin Liu, Alfred Hausladen, Raphael Nudelman
Life of this patent
Estimating the term…
Abstract
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.
Claims7
A method for treating a patient afflicted with cystic fibrosis comprising administering to said patient a therapeutically effective amount of at least one inhibitor of glutathione-dependent formaldehyde dehydrogenase.
Dependencies are inferred from the claim text.